• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PYC 4.00% 9.6¢

PYC THERAPEUTICS LIMITED

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PYC
PYC Filed Another Patent
10/05/24 23 14K
10/05/24 Last post  travelbug2 Comments Created with Sketch.  23  Views Created with Sketch.  14K 
PYC 09/05/24 23 5.2K
09/05/24 Last post  travelbug2 Comments Created with Sketch.  23  Views Created with Sketch.  5.2K 
PYC 09/05/24 3 1.3K
TRENDING NEWS

SS1: a 292,000,000 silver equivalent resource commences trading on the ASX at 11am AEST 15th May 2024

NEWS
13 May 2024
09/05/24 Last post  Malown1 Comments Created with Sketch.  3  Views Created with Sketch.  1.3K 
PYC
PYC Chart and Technical Analysis
2 3
07/05/24 126 52K
07/05/24 Last post  travelbug2 Comments Created with Sketch.  126  Views Created with Sketch.  52K 
PYC 06/05/24 9 3.6K
06/05/24 Last post  grimloq Comments Created with Sketch.  9  Views Created with Sketch.  3.6K 
PYC
PYC - General Discussion
3 4 5
03/05/24 266 117K
03/05/24 Last post  drays Comments Created with Sketch.  266  Views Created with Sketch.  117K 
PYC 01/05/24 1 855
01/05/24 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  855 
PYC 01/05/24 14 5.7K
01/05/24 Last post  hottod Comments Created with Sketch.  14  Views Created with Sketch.  5.7K 

See All Discussions arrow Created with Sketch.

Timeline

Q2 2024 Investor Webinar Presentation
09 May 09:31
 
Presentation of RP11 Clinical Trial Data at ARVO Conference
06 May 08:56
 
Ceasing to be a substantial holder
01 May 16:48
 
Q2 Investor Webinar 9 May 2024
01 May 09:47
 
Application for quotation of securities - PYC
30 Apr 09:53
 
RP11 Drug Candidate Progressing to Mid-Stage Human Trials
29 Apr 09:29
 
View More arrow Created with Sketch.
(20min delay)
Last
9.6¢
Change
-0.004(4.00%)
Mkt cap ! $447.9M
Open High Low Value Volume
10.5¢ 10.5¢ 9.5¢ $142.0K 1.431M

Buyers (Bids)

No. Vol. Price($)
2 44242 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 59134 2
View Market Depth
Last trade - 14.59pm 13/05/2024 (20 minute delay) ?
Last
9.6¢
  Change
-0.004 ( 4.19 %)
Open High Low Volume
10.5¢ 10.5¢ 9.5¢ 534939
Last updated 14.59pm 13/05/2024 ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.